Related Experiment Video
Updated: Aug 23, 2026
Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
Modulating expression of peripherin/rds in transgenic mice: critical levels and the effect of overexpression
May Nour1, Xi-Qin Ding, Heidi Stricker
1Department of Cell Biology, University of Oklahoma Health Sciences Center, Oklahoma City, 73104, USA.
Purpose:
Mutations in the photoreceptor-specific protein peripherin/rds are associated with multiple retinal diseases. To date, attempts to achieve complete structural and functional rescue in animal models of peripherin/rds-induced retinal degeneration have not been successful. Gene therapy-directed approaches have been hindered by the haploinsufficiency phenotype, which dictates well-regulated expression of peripherin/rds protein levels.
Methods:
Using a transgenic mouse line expressing wild-type peripherin/rds (NMP), the authors evaluated the critical in vivo level of peripherin/rds needed to maintain photoreceptor structure and ERG function and assessed the consequences of peripherin/rds overexpression in both rods and cones by Western blot and immunoprecipitation analyses, immunohistochemistry, electron microscopy, and electroretinography. The NMP transgene included a C-terminal modification (P341Q) to facilitate detection of the transgenic protein in the presence of wild-type peripherin/rds, using the monoclonal antibody 3B6.
Results:
Peripherin/rds protein levels in NMP homozygotes were approximately 60% of wild-type levels. Western blot and immunoprecipitation analyses confirmed normal biochemical properties of the NMP protein when compared with wild-type peripherin/rds. Immunohistochemistry demonstrated appropriate localization of transgenic peripherin/rds protein to the disc rim region of photoreceptor outer segments. Total peripherin/rds levels in the retina were modulated by crossing NMP transgenic mice into different rds genetic backgrounds. A positive correlation was observed between peripherin/rds expression levels and the structural and functional integrity of photoreceptor outer segments. Overexpression of peripherin/rds caused no detectable adverse effects on rod or cone structure and function.
Conclusions:
These findings may have significant implications regarding therapeutic intervention in peripherin/rds-associated retinal diseases.
Insights
Peripherin/rds protein levels are critical for photoreceptor health. This study shows that higher levels of peripherin/rds protein, even with overexpression, do not harm retinal structure or function, suggesting new therapeutic avenues.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Mutations in peripherin/rds cause retinal diseases.
- Previous attempts at gene therapy have been limited by the need for precise peripherin/rds expression levels.
Purpose of the Study:
- To determine the critical in vivo level of peripherin/rds for photoreceptor health.
- To assess the effects of peripherin/rds overexpression on rod and cone structure and function.
Main Methods:
- Utilized a transgenic mouse model (NMP) expressing a detectable wild-type peripherin/rds.
- Employed Western blot, immunoprecipitation, immunohistochemistry, electron microscopy, and electroretinography.
- Modulated peripherin/rds levels by crossing NMP mice with different rds genetic backgrounds.
Main Results:
- Peripherin/rds levels positively correlated with photoreceptor outer segment integrity.
- Overexpression of peripherin/rds did not induce adverse effects on rod or cone structure or function.
- Transgenic peripherin/rds protein was correctly localized to the photoreceptor outer segments.
Conclusions:
- Findings suggest that increased peripherin/rds levels are tolerated and beneficial for photoreceptor health.
- This has significant implications for developing gene therapies for peripherin/rds-associated retinal diseases.
